GGenEdit Team
GenEdit
Last updated: February 23, 2026
GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery. Healthcare Biotech Therapeutics
Sequoia, $26M Series A in 2021
GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery. Healthcare Biotech Therapeutics
Sequoia, $26M Series A in 2021
- Series A • Sequoia, $26M Series A in 2021
Founder Intelligence Brief: GenEdit Team
This profile is built to help readers move from a founder name to decision-ready context. GenEdit Team is mapped to GenEdit in the Healthcare category, with current stage context as Series A. The primary operating market is San Francisco Bay Area, California, USA, which connects this profile directly to regional ecosystem pages and related industry hubs.
Funding visibility currently shows $26.00M, with the latest mapped round as Series A (Sequoia, $26M Series A in 2021). This makes it easier to evaluate growth narrative against capital stage rather than reading isolated updates without baseline context.
For deeper research, combine this founder page with the company profile, company news hub, country newsroom and Healthcare startup list. This route gives a cleaner picture of execution, market demand, and competitive movement.
Research flow
- Validate company baseline on company intelligence.
- Compare market peers via Healthcare industry routes and Series A stage pages.
- Track fresh updates in newsroom coverage and signals feed.
Operating context
- Geography: United States directory.
- Stage signal: Series A funding coverage.
- Hiring status: Open Roles.
Related Founders
More founders in Healthcare.
Want to get featured on 100Xfounder?
Get your founder profile published with verified funding and hiring context.
Related Pillar Pages
Access the country, industry, stage, startup taxonomy, and newsroom routes connected to this founder.
FAQs About GenEdit Team
Common questions people ask about this profile.
Who is GenEdit Team?
GenEdit Team is the founder profile listed on 100Xfounder for GenEdit, tracked for market signals, company intelligence, and operator-level context.
What does GenEdit do?
GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery. Healthcare Biotech Therapeutics
Where is GenEdit based?
GenEdit is listed as operating from San Francisco Bay Area, California, USA.
What is the current funding stage of GenEdit?
GenEdit is currently categorized at Series A on 100Xfounder. Funding signal: Sequoia, $26M Series A in 2021
What is the latest funding round for GenEdit?
The latest tracked round for GenEdit is Series A Sequoia, $26M Series A in 2021. Total tracked rounds: 1.
Is GenEdit hiring right now?
Current hiring signal for GenEdit: Open Roles.
Is GenEdit Team's profile verified?
Yes. GenEdit Team's profile is marked as verified on 100Xfounder as of July 23, 2026.
How can I connect with GenEdit Team?
You can use the profile action buttons and listed links on 100Xfounder. Contact context is provided with business relevance and profile metadata for www.genedit.com.
What technologies are associated with GenEdit?
GenEdit is associated with Python, GCP, BigQuery, and React based on current profile intelligence.